Magenta Therapeutics, Inc. (24) | Lease Agreements (2)
- Second Amendment to Sublease Agreement, dated as of August 19, 2020, by and between the Registrant and Novartis Institutes for BioMedical Research, Inc (Filed With SEC on March 3, 2021)
- First Amendment to Sublease by and between Novartis Institutes for BioMedical Research, Inc. and the Registrant, dated as of December 13, 2018 (Filed With SEC on April 29, 2019)
